Page last updated: 2024-08-24

telmisartan and Myocardial Ischemia

telmisartan has been researched along with Myocardial Ischemia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hedner, T; Kjeldsen, SE; Narkiewicz, K; Oparil, S	1
Richard Conti, C	1
Guirguis-Blake, J	1
Drexler, H; Fuchs, M; Grote, K; Hilfiker, A; Hilfiker-Kleiner, D; Kaminska, A; Kaminski, K; Kiian, I; Klein, G; Podewski, E; Wollert, KC	1

Reviews

1 review(s) available for telmisartan and Myocardial Ischemia

Article	Year
Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease. American family physician, 2012, Jul-01, Volume: 86, Issue:1 Topics: Adrenergic beta-Antagonists; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Cough; Dizziness; Drug Therapy, Combination; Headache; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Patient Readmission; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Telmisartan	2012

Article

Year

Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease.

American family physician, 2012, Jul-01, Volume: 86, Issue:1

Topics: Adrenergic beta-Antagonists; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Cough; Dizziness; Drug Therapy, Combination; Headache; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Patient Readmission; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Telmisartan

2012

Other Studies

3 other study(ies) available for telmisartan and Myocardial Ischemia

Article	Year
ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading? Blood pressure, 2009, Volume: 18, Issue:1-2 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Comorbidity; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Ischemia; Ramipril; Renal Insufficiency; Risk; Stroke; Telmisartan; Treatment Outcome	2009
Clinical practice guides. Clinical cardiology, 2009, Volume: 32, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Data Interpretation, Statistical; Humans; Myocardial Ischemia; Ramipril; Randomized Controlled Trials as Topic; Statistics as Topic; Telmisartan	2009
Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation. Circulation, 2004, May-11, Volume: 109, Issue:18 Topics: Alkaloids; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Benzophenanthridines; Cell Movement; Cells, Cultured; Cysteine-Rich Protein 61; Flavonoids; Gene Expression Regulation; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Interleukin-6; Leukemia Inhibitory Factor; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Myocytes, Smooth Muscle; Naphthalenes; Neovascularization, Physiologic; Norepinephrine; Paracrine Communication; Phenanthridines; Phenylephrine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; RNA, Messenger; Stress, Mechanical; Telmisartan; Tumor Necrosis Factor-alpha	2004